BiotechTube
Home/OraSure Technologies/Nancy J. Gagliano
NJ

Nancy J. Gagliano

Independent Director

OraSure Technologies

Therapeutic Areas

Infectious DiseaseSubstance Abuse

OraSure Technologies Pipeline

DrugIndicationPhase
OraQuick® HCV Rapid Antibody TestHepatitis C (HCV) infectionApproved
OraQuick® HIV Self-TestHIV-1/2 infectionApproved
InteliSwab® COVID-19 Rapid Antigen TestSARS-CoV-2 infectionApproved
Oral Fluid Collection for Molecular TestingMulti-disease sample collectionApproved
Next-Generation Rapid TestsUndisclosed Infectious DiseasesResearch
Substance Abuse Testing AssaysDrugs of abuse detectionDevelopment

Leadership Team at OraSure Technologies

SS
Stephen S. Tang
President, CEO, Director
ML
Michele L. Fabrizi
Chief Financial Officer
KW
Kathleen Weber
SVP, Clinical, Regulatory, and Quality
RJ
Robert J. Shaffer
SVP, General Counsel, Corporate Secretary
View full OraSure Technologies profile